Nathan T. Smith, PharmD, BCPS recalls the clinical presentation of gender incongruence, identifies current treatment options for transgender men and women and describes potential cardiovascular risks associated with gender-affirming hormone therapy.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.